When it comes to medical services, it can be challenging to know how much you'll be paying until you receive the bill. Unlike other services, such as home repairs or plane tickets, it's not always possible to shop around for the best price. However, a new federal rule called the Transparency in Coverage rule aims to change this by requiring hospitals to make their prices public and provide consumer-friendly tools for patients to estimate their costs.
Cardiovascular disease is the most expensive chronic disease in the United States, making it crucial to understand the costs associated with diagnosis and treatment. Researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Harvard-affiliated Beth Israel Deaconess Medical Center took advantage of the new transparency rule to compare prices for six common heart tests and procedures across 20 top-rated hospitals.
The study, published in the September 2022 JAMA Internal Medicine, found striking price differences for the same tests and procedures across different hospitals. For example:
There was a 10-fold difference in the median price of an echocardiogram (heart ultrasound) across the hospitals.
Price differences were even greater for procedures like implanting a pacemaker or percutaneous coronary interventions (minimally invasive procedures to open clogged heart arteries, such as placing a stent).
Within a single hospital, the price of a stress test varied fivefold depending on the patient's commercial insurance company.
These price variations are likely not a reflection of the quality of care, as the study focused on top-rated hospitals. Instead, they are influenced by the negotiating power between hospitals and insurance companies, which is affected by factors such as location, size, and popularity.
Although patients never see the payer-negotiated prices agreed upon by hospitals and insurance companies, high prices can still affect them through co-pays, deductibles, and overall healthcare costs. When insurance companies pay high prices, those costs may trickle down to patients in various ways.
While the Transparency in Coverage rule is a step in the right direction, accessing and interpreting the cost data remains challenging for patients. Researchers and policymakers are working to make high-quality price data more easily accessible, which will help tackle important policy issues related to the high cost of cardiovascular care.
As a patient, it's essential to stay informed about your healthcare costs and work with your healthcare provider and insurance company to understand your options. By advocating for greater price transparency and accessibility, we can work towards a more affordable and equitable healthcare system for all.
For more information on the cost of heart tests and procedures, visit:
Williams syndrome is a rare genetic disorder that affects various parts of the body and causes learning difficulties. Children with this condition may have unique facial [...]
Have you ever felt your heart beat very fast or skip a beat? This sensation, known as palpitations, is usually harmless. However, in some cases, it could be a sign of a rare [...]
Munchausen Syndrome by Proxy (MSP) is a rare psychological disorder where a caregiver, often a mother, fabricates or exaggerates a child's illness to gain attention and [...]